108 related articles for article (PubMed ID: 2823858)
1. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
[TBL] [Abstract][Full Text] [Related]
2. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
Lammers AM; van de Kerkhof PC; Mier PD
Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
van de Kerkhof PC; Lammers AM; Mier PD; Happle R
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562
[No Abstract] [Full Text] [Related]
5. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
[TBL] [Abstract][Full Text] [Related]
7. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
[TBL] [Abstract][Full Text] [Related]
8. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
[TBL] [Abstract][Full Text] [Related]
9. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4.
Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC
Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566
[TBL] [Abstract][Full Text] [Related]
10. The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis.
Maurice PD; Camp RD; Allen BR
Prostaglandins; 1987 Jun; 33(6):807-18. PubMed ID: 2823314
[TBL] [Abstract][Full Text] [Related]
11. Dithranol modulates the leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes.
Chang A; Alkemade H; van de Kerkhof PC
J Invest Dermatol; 1989 Jun; 92(6):806-8. PubMed ID: 2542415
[TBL] [Abstract][Full Text] [Related]
12. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
[TBL] [Abstract][Full Text] [Related]
13. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
Wong E; Camp RD; Greaves MW
J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
[TBL] [Abstract][Full Text] [Related]
14. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.
Schopf RE; Höcher J; Rehder M; Färber L; Morsches B
Arch Dermatol Res; 1992; 284(4):227-31. PubMed ID: 1417069
[TBL] [Abstract][Full Text] [Related]
15. Areca nut extracts-activated secretion of leukotriene B4, and phosphorylation of p38 mitogen-activated protein kinase and elevated intracellular calcium concentrations in human polymorphonuclear leukocytes.
Hung SL; Lin YJ; Chien EJ; Liu WG; Chang HW; Liu TY; Chen YT
J Periodontal Res; 2007 Oct; 42(5):393-401. PubMed ID: 17760816
[TBL] [Abstract][Full Text] [Related]
16. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; van de Kerkhof PC
Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
[TBL] [Abstract][Full Text] [Related]
17. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
[TBL] [Abstract][Full Text] [Related]
18. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC
Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
[TBL] [Abstract][Full Text] [Related]
20. PUVA and UVB inhibit the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; Alkemade JA; van de Kerkhof PC
Br J Dermatol; 1988 Sep; 119(3):281-7. PubMed ID: 2846029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
